|
mesonephric smooth muscle tissue development
|
GO_0061214 |
[The process whose specific outcome is the progression of smooth muscle in the mesonephros over time, from its formation to the mature structure.] |
|
kidney smooth muscle tissue development
|
GO_0072194 |
[The process whose specific outcome is the progression of smooth muscle in the kidney over time, from its formation to the mature structure.] |
|
multivesicular body assembly
|
GO_0036258 |
[The aggregation, arrangement and bonding together of a set of components to form a multivesicular body, a type of late endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm.] |
|
multivesicular body organization
|
GO_0036257 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a multivesicular body. A multivesicular body is a type of late endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm.] |
|
positive regulation of interleukin-17-mediated signaling pathway
|
GO_1903883 |
[Any process that activates or increases the frequency, rate or extent of interleukin-17-mediated signaling pathway.] |
|
regulation of interleukin-17-mediated signaling pathway
|
GO_1903881 |
[Any process that modulates the frequency, rate or extent of interleukin-17-mediated signaling pathway.] |
|
positive regulation of kidney development
|
GO_0090184 |
[Any process that increases the rate, frequency or extent of kidney development. Kidney development is the process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.] |
|
negative regulation of interleukin-17-mediated signaling pathway
|
GO_1903882 |
[Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-17-mediated signaling pathway.] |
|
mesonephric juxtaglomerular apparatus development
|
GO_0061212 |
[The process whose specific outcome is the progression of the juxtaglomerular apparatus in the mesonephros over time, from its formation to the mature structure. The juxtaglomerular apparatus is an anatomical structure which consists of juxtaglomerular cells, extraglomerular mesangial cells and the macula densa. The juxtaglomerular apparatus lies adjacent to the glomerulus and regulates kidney function by maintaining the blood flow to the kidney and the filtration rate.] |
|
juxtaglomerular apparatus development
|
GO_0072051 |
[The process whose specific outcome is the progression of the juxtaglomerular apparatus over time, from its formation to the mature structure. The juxtaglomerular apparatus is an anatomical structure that lies adjacent to the glomerulus and regulates kidney function.] |
|
cellular response to methylamine
|
GO_0036256 |
[Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylamine stimulus.] |
|
response to methylamine
|
GO_0036255 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylamine stimulus.] |
|
negative regulation of chemokine (C-C motif) ligand 20 production
|
GO_1903885 |
[Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-C motif) ligand 20 production.] |
|
regulation of chemokine (C-C motif) ligand 20 production
|
GO_1903884 |
[Any process that modulates the frequency, rate or extent of chemokine (C-C motif) ligand 20 production.] |
|
mesonephric collecting duct development
|
GO_0061211 |
[The process whose specific outcome is the progression of a collecting duct in the mesonephros over time, from its formation to the mature structure. The collecting duct regulates water, electrolyte and acid-base balance. The collecting duct is the final common path through which urine flows before entering the ureter and then emptying into the bladder.] |
|
collecting duct development
|
GO_0072044 |
[The process whose specific outcome is the progression of a collecting duct over time, from its formation to the mature structure. The collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance. It is the final common path through which urine flows before entering the ureter and then emptying into the bladder.] |
|
obsolete regulation of microfilament motor activity
|
GO_0120079 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of microfilament motor activity.] |
|
negative regulation of kidney development
|
GO_0090185 |
[Any process that decreases the rate, frequency or extent of kidney development. Kidney development is the process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.] |
|
cell adhesion involved in sprouting angiogenesis
|
GO_0120078 |
[The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules that contributes to the formation of a blood vessel network.] |
|
GO_1903887
|
GO_1903887 |
|